Insider Trading Activity La Jolla Pharmaceutical (NASDAQ:LJPC) – COO Bought 1,000 shares of Stock

0

Insider Trading Activity For La Jolla Pharmaceutical (NASDAQ:LJPC)

Jennifer Carver , COO of La Jolla Pharmaceutical (NASDAQ:LJPC) reportedly Bought 1,000 shares of the company’s stock at an average price of 33.22 for a total transaction amount of $33,220.00 SEC Form

Insider Trading History For La Jolla Pharmaceutical (NASDAQ:LJPC)

  • On 2/7/2014 George F Tidmarsh, CEO, bought 3,000 with an average share price of $7.25 per share and the total transaction amounting to $21,750.00.View SEC Filing
  • On 4/14/2014 George Tidmarsh, CEO, bought 8,000 with an average share price of $9.53 per share and the total transaction amounting to $76,240.00.View SEC Filing
  • On 5/21/2014 George Tidmarsh, CEO, bought 12,000 with an average share price of $7.37 per share and the total transaction amounting to $88,440.00.View SEC Filing
  • On 7/23/2014 George F Tidmarsh, CEO, bought 19,000 with an average share price of $10.50 per share and the total transaction amounting to $199,500.00.View SEC Filing
  • On 9/18/2014 George F Tidmarsh, CEO, bought 5,000 with an average share price of $9.18 per share and the total transaction amounting to $45,900.00.View SEC Filing
  • On 9/24/2014 Kevin C Tang, Director, bought 95,000 with an average share price of $9.10 per share and the total transaction amounting to $864,500.00.View SEC Filing
  • On 9/25/2014 Kevin C Tang, Director, bought 30,500 with an average share price of $9.17 per share and the total transaction amounting to $279,685.00.View SEC Filing
  • Analyst Ratings History For La Jolla Pharmaceutical (NASDAQ:LJPC)

    • On 5/24/2016 Lake Street Capital Initiated Coverage of rating Buy with a price target of $25.00
    • On 4/30/2017 Noble Financial Reiterated Rating Buy
    • On 10/3/2017 Jefferies Group Reiterated Rating Buy with a price target of $40.00
    • On 12/22/2017 JPMorgan Chase & Co. Reiterated Rating Sell
    • On 12/22/2017 Chardan Capital Reiterated Rating Buy with a price target of $90.00
    • On 12/22/2017 Cowen Reiterated Rating Buy with a price target of $55.00
    • On 12/28/2017 SunTrust Banks Set Price Target of rating Buy with a price target of $57.00 to $65.00

    Recent Trading Activity for La Jolla Pharmaceutical (NASDAQ:LJPC)
    Shares of La Jolla Pharmaceutical closed the previous trading session at 32.18 down -0.27 0.83% with 287700 shares trading hands.